These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 74389)

  • 1. Fragments Ba and Bb derived from guinea pig factor B of the properdin system: purification, characterization, and biologic activities.
    Hamuro J; Hadding U; Bitter-Suermann D
    J Immunol; 1978 Feb; 120(2):438-44. PubMed ID: 74389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of rat complement factor B and its interaction with cell-bound human C3.
    Daha MR; van Es LA
    Immunology; 1980 Dec; 41(4):849-55. PubMed ID: 6906329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two forms of guinea pig factor B of the alternative complement pathway with different molecular weights.
    Matsushita M; Okada H
    Mol Immunol; 1989 Jul; 26(7):669-76. PubMed ID: 2779589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. II. Physico-chemical characterization of the activated complex.
    Miyama A; Kato T; Yokoo J; Kashiba S
    Biken J; 1975 Dec; 18(4):205-14. PubMed ID: 1218075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the CNBr peptides generated from the factor B cleavage fragments, Ba and Bb, by molecular exclusion high performance liquid chromatography.
    Niemann MA; Mole JE
    Immunol Commun; 1982; 11(1):47-58. PubMed ID: 6920359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of induction of IL-1 production in human monocytes by complement fragments.
    Arend WP; Massoni RJ; Niemann MA; Giclas PC
    J Immunol; 1989 Jan; 142(1):173-8. PubMed ID: 2783323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of a human serum protein ("factor E") which enhances cobra venom factor-induced indirect lysis. Identification with the fifth component of complement.
    Lynen R; Vogt W; Schmidt G; Dieminger L
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):105-16. PubMed ID: 134530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alternative complement pathway in chickens. Purification of factor B and production of a monospecific antibody against it.
    Koch C
    Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):253-9. PubMed ID: 3646826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ba fragment of complement factor B inhibits human B lymphocyte proliferation.
    Ambrus JL; Peters MG; Fauci AS; Brown EJ
    J Immunol; 1990 Mar; 144(5):1549-53. PubMed ID: 2307833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.
    Meuer S; Becker S; Hadding U; Bitter-Suermann D
    Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):135-46. PubMed ID: 77089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen.
    Sundsmo JS; Wood LM
    J Immunol; 1981 Sep; 127(3):877-80. PubMed ID: 6911148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifth component of guinea pig complement: purification and characterization.
    Kinoshita T; Hong K; Kondo K; Inoue K
    J Immunol; 1981 Jun; 126(6):2414-8. PubMed ID: 7229382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.
    Vogt W; Schmidt G; Dieminger L; Lynen R
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):440-55. PubMed ID: 126576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of guinea pig lymphocyte-derived chemotactic factor for fibroblasts.
    Postlethwaite AE; Kang AH
    J Immunol; 1980 Mar; 124(3):1462-6. PubMed ID: 7358987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
    Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
    Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human factor B activity of the properdin system by human and guinea-pig sera.
    Lambré C
    Ann Immunol (Paris); 1979; 130C(1):71-8. PubMed ID: 373582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection and characterization of a membrane protein with Factor B-like activity on human lymphoid cells.
    Woo P; Lachmann PJ
    Immunology; 1981 Nov; 44(3):629-39. PubMed ID: 6976310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.
    Ruddy S; Austen KF; Goetzl EJ
    J Clin Invest; 1975 Mar; 55(3):587-92. PubMed ID: 1167871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid.
    Vogt W; Schmidt G; Lynen R; Dieminger L
    J Immunol; 1975 Feb; 114(2 Pt 1):671-7. PubMed ID: 804510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of factor B and C3 in guinea pig serum by zymosan or by activated properdin depends on the presence of factor D.
    Brade V; Bentley C; Kossorotow A; Bitter-Suermann D
    Monogr Allergy; 1977; 12():83-5. PubMed ID: 917024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.